Identification and validation of a plasticity driver of Combined Hepatocellular-Cholangiocarcinoma using functional interspecies comparison
Identification and validation of a plasticity driver of Combined Hepatocellular-Cholangiocarcinoma using functional interspecies comparison
复制标题
使用功能种间比较鉴定和验证联合肝细胞胆管癌的可塑性驱动因素
DOI:
10.1055/s-0041-1740768
复制
发表时间:
2022
期刊:
影响因子:
--
通讯作者:
Pellegrino R. Longerich T
中科院分区:
文献类型:
--
作者:
Ganjian N;Abadi Z;Trompak O;Geffers R;Zender L;Pellegrino R. Longerich T
Hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA) represent the two most common types of primary liver cancer, while combined HCC-CCA (cHCC-CCA) is rarely observed. Lineage-tracing studies in mice have shown that cholangiocarcinoma may develop from hepatocytes, while ductular cells may also give rise to HCC as a result of their plasticity. The aim of this project was to identify molecular mechanisms leading to a phenotypic switch in tumor cells resulting in cHCC-CCA formation.Exome and transcriptome sequencing of HCC and CCA components of fifteen human cHCC-CCA samples was conducted. Data integration identified 57 potential phenotypic driver genes which were altered between both tumor compartments. In vivo RNAi screening was used to validate the candidate genes using two transposon-based mosaic mouse models (HCC model: MYC-AKT1 in C57BL/6 mice; iCCA model: KRASG12V in p19-/-mice). Individual tumor nodules displaying a phenotypic switch in tumor type based on histopathological evaluation were sequenced to identify the expressed shRNA.